| Literature DB >> 26146421 |
M B Betancor1, M Sprague1, O Sayanova2, S Usher2, P J Campbell3, J A Napier2, M J Caballero4, D R Tocher1.
Abstract
Currently, one alternative for dietary fish oil (FO) in aquafeeds is vegetable oils (VO) that are devoid of omega-3 (n-3) long-chain polyunsaturated fatty acids (LC-PUFAs). Entirely new sources of n-3 LC-PUFA such as eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids through de novo production are a potential solution to fill the gap between supply and demand of these important nutrients. Camelina sativa was metabolically engineered to produce a seed oil (ECO) with > 20% EPA and its potential to substitute for FO in Atlantic salmon feeds was tested. Fish were fed with one of the three experimental diets containing FO, wild-type camelina oil (WCO) or ECO as the sole lipid sources for 7 weeks. Inclusion of ECO did not affect any of the performance parameters studied and enhanced apparent digestibility of individual n-6 and n-3 PUFA compared to dietary WCO. High levels of EPA were maintained in brain, liver and intestine (pyloric caeca), and levels of DPA and DHA were increased in liver and intestine of fish fed ECO compared to fish fed WCO likely due to increased LC-PUFA biosynthesis based on up-regulation of the genes. Fish fed ECO showed slight lipid accumulation within hepatocytes similar to that with WCO, although not significantly different to fish fed FO. The regulation of a small number of genes could be attributed to the specific effect of ECO (311 features) with metabolism being the most affected category. The EPA oil from transgenic Camelina (ECO) could be used as a substitute for FO, however it is a hybrid oil containing both FO (EPA) and VO (18:2n-6) fatty acid signatures that resulted in similarly mixed metabolic and physiological responses.Entities:
Keywords: Aquaculture; Camelina; EPA; Fish oil; Pyloric caeca microarray
Year: 2015 PMID: 26146421 PMCID: PMC4459488 DOI: 10.1016/j.aquaculture.2015.03.020
Source DB: PubMed Journal: Aquaculture ISSN: 0044-8486 Impact factor: 4.242
Formulations, proximate and fatty acid compositions (percentage of fatty acids) of the experimental feeds.
| FO | WCO | ECO | |
|---|---|---|---|
| Fish meal, NA LT 70 | 24.5 | 24.5 | 24.5 |
| Fish meal, SA 68 Superprime | 24.5 | 24.5 | 24.5 |
| Soy protein concentrate (60%) | 14.4 | 14.4 | 14.4 |
| Wheat gluten | 4.9 | 4.9 | 4.9 |
| Wheat | 12.8 | 12.8 | 12.8 |
| Fish oil | 17.5 | – | – |
| Wild-type Camelina oil (Wt-CO) | – | 17.5 | – |
| EPA-Camelina oil (Tr-CO) | – | – | 17.5 |
| Monocalcium phosphate | 0.6 | 0.6 | 0.6 |
| Vitamins/minerals | 0.8 | 0.8 | 0.8 |
| Yttrium oxide | 0.05 | 0.05 | 0.05 |
| Dry matter (%) | 91.8 | 91.3 | 92.6 |
| Protein (%) | 45.4 | 46.1 | 47.1 |
| Fat (%) | 24.9 | 23.1 | 23.9 |
| Ash | 8.6 | 8.5 | 8.5 |
| Gross energy (Kj/g) | 22.5 | 22.4 | 22.7 |
| Ʃ saturated1 | 30.7 | 13.2 | 17.4 |
| Ʃ monounsaturated2 | 26.6 | 36.4 | 18.2 |
| 20:2n-6 | 0.2 | 1.2 | 1.2 |
| 20:3n-6 | 0.1 | 0.0 | 1.2 |
| 20:4n-6 | 0.9 | 0.1 | 2.5 |
| Ʃ n-6 PUFA3 | 5.3 | 18.6 | 25.7 |
| 20:3n-3 | 0.1 | 0.8 | 1.0 |
| 20:4n-3 | 0.7 | 0.1 | 3.0 |
| 20:5n-3 | 15.9 | 2.1 | 18.7 |
| 22:5n-3 | 1.8 | 0.3 | 1.0 |
| 22:6n-3 | 11.2 | 2.5 | 2.4 |
| Ʃ n-3 PUFA | 33.2 | 31.2 | 38.0 |
| Ʃ PUFA4 | 42.7 | 50.4 | 64.4 |
| Total n-3 LC-PUFA | 29.5 | 5.0 | 25.2 |
1Contains 15:0, 22:0 and 24:0.
2Contains 16:1n-9, 20:1n-11, 20:1n-7, 22:1n-9 and 24:1n-9.
3Contains 22:4n-6 and 22:5n-6;4contains C16 PUFA.
Fish and FO, fish oil and respective feed.
LC-PUFA, long-chain polyunsaturated fatty acid (sum of 20:4n-3, 20:5n-3 22:5n-3 and 22:6n-3).
n.d.: not detected.
Growth performance, survival, feed utilisation and basic biometry over the 7-week experimental period.
| FO | WCO | ECO | |
|---|---|---|---|
| Final weight (g) | 196.5 ± 26.3 | 200.5 ± 28.5 | 207.9 ± 26.5 |
| Total length (cm) | 25.0 ± 1.0 | 24.8 ± 1.4 | 25.0 ± 1.0 |
| Survival (%) | 100.0 ± 0.0 | 100.0 ± 0.0 | 100.0 ± 0.0 |
| HSI | 0.9 ± 0.1 | 0.9 ± 0.1 | 0.9 ± 0.1 |
| VSI | 9.5 ± 0.9 | 9.6 ± 1.2 | 9.9 ± 0.7 |
| FI (g/tank) | 4200.0 ± 155.0 | 4203.0 ± 97.0 | 4257.0 ± 216.0 |
| FCR | 0.9 ± 0.0 | 0.9 ± 0.0 | 0.9 ± 0.0 |
| SGR | 1.9 ± 0.0 | 1.9 ± 0.0 | 2.0 ± 0.1 |
| k | 1.3 ± 0.0 | 1.3 ± 0.0 | 1.3 ± 0.0 |
Data are means ± SD (n = 3). There were no significant differences between treatments in any parameter. FCR, feed conversion ratio; FI, feed intake; HSI, hepato-somatic index; k, condition factor; SGR, specific growth rate; VSI, viscera-somatic index.
Apparent digestibility coefficient (ADC) of lipid and fatty acids in Atlantic salmon fed the three experimental diets differing in oil source.
| FO | WCO | ECO | |
|---|---|---|---|
| Fat ADC | 90.6 ± 1.3b | 96.8 ± 0.1a | 95.7 ± 0.3a |
| 14:0 | 86.9 ± 1.8b | 97.6 ± 0.2a | 97.0 ± 0.0a |
| 15:0 | 86.3 ± 0.5c | 97.5 ± 0.2a | 95.9 ± 0.2b |
| 16:0 | 83.9 ± 0.9c | 96.8 ± 0.2a | 95.2 ± 0.3b |
| 18:0 | 78.8 ± 1.4c | 96.1 ± 0.4a | 93.1 ± 0.7b |
| Total saturated1 | 84.3 ± 0.8c | 96.5 ± 0.3a | 94.1 ± 0.5b |
| 16:1n-7 | 97.5 ± 0.3b | 98.6 ± 0.1a | 98.3 ± 0.1a |
| 18:1n-9 | 96.5 ± 0.4c | 99.2 ± 0.1a | 98.3 ± 0.1b |
| 18:1n-7 | 98.8 ± 0.0 | 98.0 ± 1.7 | 95.8 ± 0.9 |
| 20:1n-9 | 94.4 ± 0.6c | 99.1 ± 0.1a | 98.4 ± 0.2b |
| 20:1n-7 | 88.5 ± 1.5b | 99.2 ± 0.1a | 98.4 ± 0.2a |
| 22:1n-11 | 93.3 ± 0.8c | 98.0 ± 0.1a | 96.8 ± 0.1b |
| 22:1n-9 | 93.2 ± 0.7c | 98.7 ± 0.1a | 97.4 ± 0.3b |
| Total monoenes2 | 95.9 ± 0.5c | 99.0 ± 0.1a | 98.1 ± 0.2b |
| 18:2n-6 | 95.7 ± 0.4b | 99.2 ± 0.0a | 99.1 ± 0.1a |
| 18:3n-6 | 88.5 ± 1.1c | 96.4 ± 0.4b | 99.7 ± 0.7a |
| 20:2n-6 | 95.1 ± 0.6c | 99.3 ± 0.1a | 98.8 ± 0.1b |
| 20:4n-6 | 98.8 ± 0.1b | 97.4 ± 0.1c | 99.6 ± 0.1a |
| Total n-6 PUFA3 | 96.0 ± 0.4b | 99.2 ± 0.1a | 99.2 ± 0.1a |
| 18:3n-3 | 97.6 ± 0.2b | 99.7 ± 0.0a | 99.5 ± 0.1a |
| 18:4n-3 | 99.3 ± 0.1 | 99.3 ± 0.0 | 99.6 ± 0.1 |
| 20:3n-3 | 92.0 ± 1.4b | 99.4 ± 0.1a | 99.2 ± 0.1a |
| 20:4n-3 | 98.7 ± 0.2b | 98.1 ± 0.1c | 99.6 ± 0.1a |
| 20:5n-3 | 99.3 ± 0.1b | 98.5 ± 0.1c | 99.6 ± 0.1a |
| 22:5n-3 | 98.5 ± 0.2a | 96.9 ± 0.1b | 98.8 ± 0.2a |
| 22:6n-3 | 98.1 ± 0.2a | 96.6 ± 0.2b | 96.7 ± 0.4b |
| Total n-3 PUFA | 98.8 ± 0.1b | 99.3 ± 0.0a | 99.4 ± 0.1a |
| Total PUFA4 | 98.5 ± 0.1b | 99.3 ± 0.1a | 99.3 ± 0.1a |
Data expressed as means ± SD (n = 3).
Different superscript letters within a row denote significant differences among diets.
Statistical differences were determined by one-way ANOVA with Tukey's comparison test (p < 0.05).
1Contains 15:0, 22:0 and 24:0.
2Contains 16:1n-9 and 24:1n-9.
3contains 22:4n-6 and 22:5n-6.
4Contains C16 PUFA. ECO, feed containing oil from transgenic Camelina.
FO, fish oil feed.
LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3).
WCO, feed containing oil from wild-type Camelina.
Fig. 1Fatty acid compositions of the three experimental feeds and faeces (area %) showing preferential order of absorption with differing degree of unsaturation of dietary fatty acids.
Lipid content (percentage of wet weight) and fatty acid compositions (percentage of total fatty acids) of total lipid of pyloric caeca after 7 weeks of feeding the experimental diets.
| FO | WCO | ECO | |
|---|---|---|---|
| Lipid content | 28.5 ± 1.9 | 24.8 ± 1.9 | 24.3 ± 1.4 |
| 14:0 | 5.5 ± 0.1a | 1.9 ± 0.1b | 2.0 ± 0.1b |
| 16:0 | 15.2 ± 0.1a | 9.4 ± 0.2c | 10.2 ± 0.3b |
| 18:0 | 3.4 ± 0.0b | 3.1 ± 0.0c | 4.2 ± 0.1a |
| 20:0 | 0.2 ± 0.0c | 0.8 ± 0.0b | 1.1 ± 0.0a |
| Total saturated1 | 24.7 ± 0.2a | 15.5 ± 0.2b | 18.0 ± 0.5c |
| 16:1n-7 | 6.8 ± 0.1a | 2.3 ± 0.1b | 2.4 ± 0.0b |
| 18:1n-9 | 18.4 ± 0.2b | 21.8 ± 0.4a | 16.1 ± 0.4c |
| 18:1n-7 | 3.6 ± 0.0a | 2.1 ± 0.0c | 2.3 ± 0.1b |
| 20:1n-11 | 0.3 ± 0.0 | n.d. | n.d. |
| 20:1n-9 | 3.1 ± 0.1c | 9.4 ± 0.2a | 5.4 ± 0.2b |
| 20:1n-7 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.4 ± 0.0 |
| 22:1n-11 | 2.7 ± 0.3 | 2.4 ± 0.2 | 1.5 ± 1.2 |
| 22:1n-9 | 0.4 ± 0.0 | 1.3 ± 0.1 | 1.2 ± 1.0 |
| Total monoenes2 | 36.3 ± 0.3b | 40.3 ± 0.5a | 30.0 ± 0.1c |
| 18:2n-6 | 6.6 ± 0.1c | 14.7 ± 0.3b | 16.4 ± 0.0a |
| 18:3n-6 | 0.2 ± 0.0c | 0.3 ± 0.0b | 0.8 ± 0.0a |
| 20:2n-6 | 0.5 ± 0.0c | 1.4 ± 0.1b | 1.7 ± 0.0a |
| 20:3n-6 | 0.3 ± 0.0c | 0.4 ± 0.0b | 1.2 ± 0.0a |
| 20:4n-6 | 0.7 ± 0.1c | 0.3 ± 0.0b | 1.6 ± 0.0a |
| Total n-6 PUFA3 | 8.7 ± 0.1c | 17.2 ± 0.3b | 22.0 ± 0.1a |
| 18:3n-3 | 2.0 ± 0.1 | 14.6 ± 0.6 | 7.5 ± 0.0 |
| 18:4n-3 | 1.7 ± 0.0b | 2.1 ± 0.1a | 1.3 ± 0.0c |
| 20:3n-3 | 0.2 ± 0.0b | 1.0 ± 0.0a | 0.9 ± 0.0a |
| 20:4n-3 | 1.1 ± 0.0b | 1.0 ± 0.1b | 2.3 ± 0.0a |
| 20:5n-3 | 8.2 ± 0.1b | 2.0 ± 0.0c | 8.7 ± 0.1a |
| 22:5n-3 | 3.0 ± 0.0a | 0.8 ± 0.0b | 2.8 ± 0.1a |
| 22:6n-3 | 11.9 ± 0.4a | 4.9 ± 0.3c | 5.9 ± 0.2b |
| Total n-3 PUFA | 28.1 ± 0.4b | 26.4 ± 0.4c | 29.5 ± 0.4a |
| Total PUFA4 | 39.0 ± 0.5c | 44.2 ± 0.6b | 52.1 ± 0.5a |
| EPA + DHA | 20.1 ± 0.3a | 6.9 ± 0.4c | 14.7 ± 0.3b |
| EPA:DHA | 0.7 ± 0.0b | 0.4 ± 0.0c | 1.5 ± 0.0a |
| n-3:n-6 | 3.2 ± 0.0a | 1.5 ± 0.0b | 1.3 ± 0.0c |
| EPA + DPA + DHA | 23.1 ± 0.3a | 7.7 ± 0.4c | 17.5 ± 0.3b |
Data expressed as means ± SD (n = 3).
Different superscript letters within a row denote significant differences among diets.
Statistical differences were determined by one-way ANOVA with Tukey's comparison test (p < 0.05).
1Contains 15:0, 22:0 and 24:0.
2Contains 16:1n-9 and 24:1n-9.
3Contains 22:4n-6 and 22:5n-6.
4Contains C16 PUFA. ECO, feed containing oil from transgenic Camelina.
FO, fish oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3).
WCO, feed containing oil from wild-type Camelina.
Lipid content (percentage of wet weight) and fatty acid compositions (percentage of total fatty acids) of total lipid of anterior intestine after 7 weeks of feeding the experimental diets.
| FO | WCO | ECO | |
|---|---|---|---|
| Lipid content | 9.8 ± 3.2 | 9.2 ± 0.5 | 8.8 ± 3.2 |
| 14:0 | 4.4 ± 0.5a | 2.3 ± 0.4b | 2.1 ± 0.4b |
| 16:0 | 15.9 ± 0.4a | 10.8 ± 0.8b | 12.5 ± 0.2b |
| 18:0 | 4.0 ± 0.4 | 3.6 ± 0.6 | 5.2 ± 0.5 |
| 20:0 | 0.3 ± 0.1b | 0.7 ± 0.0a | 1.0 ± 0.0a |
| Total saturated1 | 25.2 ± 0.4a | 17.8 ± 1.0c | 21.3 ± 0.3b |
| 16:1n-7 | 5.7 ± 0.6a | 2.6 ± 0.4b | 2.4 ± 0.4b |
| 18:1n-9 | 17.4 ± 0.7ab | 21.3 ± 1.9a | 15.4 ± 1.5b |
| 18:1n-7 | 3.4 ± 0.0a | 1.9 ± 0.2b | 2.3 ± 0.1b |
| 20:1n-11 | 0.3 ± 0.1 | 0.0 ± 0.0 | 0.1 ± 0.2 |
| 20:1n-9 | 2.9 ± 0.3c | 8.1 ± 0.3a | 4.5 ± 0.1b |
| 20:1n-7 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 |
| 22:1n-11 | 2.5 ± 0.5 | 2.4 ± 0.3 | 2.2 ± 0.4 |
| 22:1n-9 | 0.3 ± 0.1 | 1.0 ± 0.0 | 0.5 ± 0.0 |
| Total monoenes2 | 33.6 ± 1.9ab | 38.8 ± 2.5a | 28.5 ± 2.6b |
| 18:2n-6 | 6.3 ± 0.3b | 13.1 ± 0.7a | 12.6 ± 0.1a |
| 18:3n-6 | 0.2 ± 0.0 | 0.3 ± 0.0 | 0.5 ± 0.0 |
| 20:2n-6 | 0.5 ± 0.0b | 1.3 ± 0.0a | 1.5 ± 0.1a |
| 20:3n-6 | 0.3 ± 0.0b | 0.4 ± 0.1b | 1.0 ± 0.1a |
| 20:4n-6 | 1.2 ± 0.3b | 0.6 ± 0.2b | 2.3 ± 0.4a |
| Total n-6 PUFA3 | 8.9 ± 0.2c | 15.9 ± 0.4b | 18.2 ± 0.5a |
| 18:3n-3 | 1.9 ± 0.1c | 12.0 ± 0.6a | 5.6 ± 0.3b |
| 18:4n-3 | 1.4 ± 0.2ab | 1.9 ± 0.2a | 1.1 ± 0.0b |
| 20:3n-3 | 0.2 ± 0.0b | 0.8 ± 0.0a | 0.7 ± 0.1a |
| 20:4n-3 | 0.9 ± 0.1b | 1.0 ± 0.0b | 1.7 ± 0.1a |
| 20:5n-3 | 7.5 ± 0.5a | 2.6 ± 0.4b | 8.1 ± 0.7a |
| 22:5n-3 | 2.7 ± 0.2a | 1.0 ± 0.1b | 2.6 ± 0.2a |
| 22:6n-3 | 16.0 ± 2.6a | 8.1 ± 2.4b | 11.6 ± 0.8ab |
| Total n-3 PUFA | 30.6 ± 1.6 | 27.4 ± 2.2 | 31.4 ± 1.9 |
| Total PUFA4 | 41.2 ± 1.5b | 43.8 ± 1.7b | 50.2 ± 2.3a |
| EPA + DHA | 23.5 ± 2.1a | 10.7 ± 2.7b | 19.7 ± 1.5a |
| EPA:DHA | 0.5 ± 0.1 | 0.3 ± 0.1 | 0.7 ± 0.0 |
| n-3:n-6 | 3.4 ± 0.2 | 1.7 ± 0.2 | 1.7 ± 0.1 |
| EPA + DPA + DHA | 26.0 ± 1.9a | 11.7 ± 2.8b | 22.3 ± 1.6a |
Data expressed as means ± SD (n = 3).
Different superscript letters within a row denote significant differences among diets.
Statistical differences were determined by one-way ANOVA with Tukey's comparison test (p < 0.05).
1Contains 15:0, 22:0 and 24:0.
2Contains 16:1n-9 and 24:1n-9.
3Contains 22:4n-6 and 22:5n-6; 4contains C16 PUFA. ECO, feed containing oil from transgenic Camelina.
FO, fish oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3).
WCO, feed containing oil from wild-type Camelina.
Lipid content (percentage of wet weight) and fatty acid compositions (percentage of total fatty acids) of total lipid of brain after 7 weeks of feeding the experimental diets.
| FO | WCO | ECO | |
|---|---|---|---|
| Lipid content | 7.3 ± 0.1 | 8.4 ± 1.4 | 7.6 ± 0.8 |
| 14:0 | 1.1 ± 0.3 | 0.9 ± 0.3 | 0.7 ± 0.3 |
| 16:0 | 17.7 ± 0.4 | 15.1 ± 1.8 | 15.9 ± 1.0 |
| 18:0 | 7.6 ± 0.2 | 6.4 ± 1.2 | 7.2 ± 0.6 |
| 20:0 | 0.1 ± 0.0 | 0.4 ± 0.2 | 0.3 ± 0.1 |
| Total saturated | 26.9 ± 0.5 | 23.2 ± 2.5 | 24.4 ± 1.3 |
| 16:1n-7 | 2.3 ± 0.3a | 1.9 ± 0.3ab | 1.7 ± 0.2b |
| 18:1n-9 | 19.1 ± 0.8ab | 20.5 ± 1.0a | 18.4 ± 0.8b |
| 18:1n-7 | 3.3 ± 0.2a | 2.6 ± 0.1b | 2.8 ± 0.1b |
| 20:1n-11 | 0.1 ± 0.0 | 0.1 ± 0.1 | 0.1 ± 0.0 |
| 20:1n-9 | 1.6 ± 0.2b | 3.8 ± 1.3a | 2.2 ± 0.4ab |
| 20:1n-7 | 0.3 ± 0.0 | 0.3 ± 0.0 | 0.3 ± 0.0 |
| 22:1n-11 | 0.3 ± 0.1 | 0.8 ± 0.5 | 0.6 ± 0.3 |
| 22:1n-9 | 0.3 ± 0.0b | 0.6 ± 0.2a | 0.4 ± 0.0ab |
| Total monoenes2 | 32.7 ± 1.4 | 35.0 ± 2.3 | 31.1 ± 1.5 |
| 18:2n-6 | 1.2 ± 0.3 | 5.1 ± 2.4 | 3.4 ± 1.4 |
| 18:3n-6 | 0.1 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.1 |
| 20:2n-6 | 0.2 ± 0.0b | 0.6 ± 0.2a | 0.5 ± 0.1a |
| 20:3n-6 | 0.1 ± 0.0b | 0.3 ± 0.0a | 0.4 ± 0.1a |
| 20:4n-6 | 1.1 ± 0.0b | 0.8 ± 0.2c | 1.6 ± 0.0a |
| Total n-6 PUFA3 | 2.9 ± 0.3 | 7.0 ± 2.5 | 6.2 ± 1.6 |
| 18:3n-3 | 0.3 ± 0.1b | 4.7 ± 2.3a | 1.5 ± 0.6ab |
| 18:4n-3 | 0.2 ± 0.1 | 0.7 ± 0.3 | 0.3 ± 0.1 |
| 20:3n-3 | 0.1 ± 0.0c | 0.6 ± 0.1a | 0.4 ± 0.0b |
| 20:4n-3 | 0.3 ± 0.0b | 0.6 ± 0.1a | 0.7 ± 0.2a |
| 20:5n-3 | 6.2 ± 0.2a | 4.5 ± 0.6b | 7.0 ± 0.1a |
| 22:5n-3 | 2.2 ± 0.1b | 1.6 ± 0.2c | 3.0 ± 0.3a |
| 22:6n-3 | 23.4 ± 1.9 | 18.4 ± 3.9 | 20.9 ± 2.6 |
| Total n-3 PUFA | 32.9 ± 1.9 | 31.0 ± 1.9 | 33.8 ± 1.9 |
| Total PUFA4 | 35.9 ± 1.6 | 38.2 ± 0.8 | 40.1 ± 0.9 |
| EPA + DHA | 29.7 ± 2.0 | 22.8 ± 4.5 | 27.9 ± 2.5 |
| EPA:DHA | 0.3 ± 0.0 | 0.2 ± 0.0 | 0.3 ± 0.0 |
| n-3:n-6 | 11.7 ± 1.8a | 4.8 ± 1.7b | 5.7 ± 1.6b |
| EPA + DPA + DHA | 31.9 ± 2.0 | 24.5 ± 4.6 | 30.9 ± 2.8 |
Data expressed as means ± SD (n = 3). Different superscript letters within a row denote significant differences among diets.
Statistical differences were determined by one-way ANOVA with Tukey's comparison test (p < 0.05).
1Contains 15:0, 22:0 and 24:0.
2Contains 16:1n-9 and 24:1n-9.
3Contains 22:4n-6 and 22:5n-6.
4Contains C16 PUFA. ECO, feed containing oil from transgenic Camelina.
FO, fish oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3).
WCO, feed containing oil from wild-type Camelina.
Mean scores for the lipid vacuolization in liver and melanomacrophages area in head kidney of Atlantic salmon fed the experimental diets for seven weeks.
| FO | WCO | ECO | |
|---|---|---|---|
| Cytoplasmic lipid vacuolization | 0.2 ± 0.2b | 1.7 ± 0.7a | 1.5 ± 1.2ab |
| Melanomacrophage area (pixels) | 7.9 × 109 ± 3.3 × 108 | 8.8 × 109 ± 4.0 × 108 | 7.3 × 109 ± 3.7 × 108 |
ECO, feed containing oil from transgenic Camelina; FO, fish oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3); WCO, feed containing oil from wild-type Camelina. Cytoplasmic lipid vacuolization score: 0, not observed; 1, few; 2, medium; 3, severe. Different superscript letters within a row denote significant differences among diets. Statistical differences were determined by one-way ANOVA with Tukey’'s comparison test (p < 0.05).
Summary of the results of microarray analysis.
| ECO vs FO | ECO vs WCO | WCO vs FO | |
|---|---|---|---|
| Total no of probes | 44,000 | ||
| Total no of DEG | 2298 | 1152 | 1404 |
| Up-regulated genes | 1367 | 661 | 865 |
| FC 1–1.5 | 1031 | 476 | 647 |
| FC 1.5–2.5 | 323 | 176 | 204 |
| FC > 2.5 | 13 | 9 | 14 |
| Down-regulated genes | 931 | 491 | 539 |
| FC 1–1.5 | 676 | 380 | 372 |
| FC 1.5–2.5 | 237 | 98 | 156 |
| FC > 2.5 | 18 | 13 | 11 |
ECO, feed containing oil from transgenic Camelina; FO, fish oil feed; LC-PUFA, long-chain polyunsaturated fatty acids (sum of 20:4n-3, 20:5n-3, 22:5n-3 and 22:6n-3); WCO, feed containing oil from wild-type Camelina.
Fig. 2Distribution by categories of common differentially expressed genes in pyloric caeca between Atlantic salmon fed oil from transgenic camelina (ECO) (A) and wild-type camelina (WCO) (B) when compared to fish fed fish oil and between ECO and WCO (C) (Welch t-test, p < 0.05). Non-annotated genes and features corresponding to the same gene are not represented.
Fig. 3Impact of diet on pyloric caeca transcriptome of Atlantic salmon fed a diet containing oil from transgenic camelina (ECO) in comparison with fish fed diets containing fish oil (FO) or wild-type camelina oil (WCO). (A) Venn diagram representing the number of mRNA transcripts differentially expressed in the pyloric caeca of Atlantic salmon fed the ECO diet compared to fish fed the FO and WCO diets. The area of the circles is scaled to the number of transcripts (Welch test, p < 0.05). (B) Distribution by categories of common differentially expressed genes (311) in pyloric caeca between Atlantic salmon fed ECO compared to fish fed FO and WCO (Welch t-test, p < 0.05). Non-annotated genes and features corresponding to the same gene are not represented.
Fig. 4Impact of diet on pyloric caeca transcriptome of Atlantic salmon fed a diet containing fish oil (FO) in comparison with fish fed diets containing wild-type camelina oil (WCO) or oil from transgenic camelina (ECO). (A) Venn diagram representing the number of mRNA transcripts differentially expressed in the pyloric caeca of Atlantic salmon fed the FO diet compared to fish fed the WCO and ECO diets. The area of the circles is scaled to the number of transcripts (Welch test, p < 0.05). (B) Distribution by categories of common differentially expressed genes (311) in pyloric caeca between Atlantic salmon fed FO compared to fish fed WCO and ECO (Welch t-test, p < 0.05). Non-annotated genes and features corresponding to the same gene are not represented.
Fig. 5Ranking of differentially expressed pathways in Atlantic salmon pyloric caeca (PC) of common differentially expressed genes between fish fed wild type camelina oil (WCO) or high-EPA camelina oil (ECO) compared to fish fed fish oil (FO; FO/ECO and FO/WCO) diets for 7 weeks. Pathway analysis was performed using the Kyoto Encyclopedia of Genes and Genome (KEGG).